Gene · 53345
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The common p.Ile291Val variant of ERLIN1 enhances TM6SF2 function and is associated with protection against MASLD. | Med | 2024 | 38776916 | PubTator, text mining | PubMed |
| Liver Fibrosis Assessed Via Noninvasive Tests Is Associated With Incident Heart Failure in a General Population Cohort. | Clin Gastroenterol Hepatol | 2024 | 38723982 | PubTator, text mining | PubMed |
| Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population. | Genes (Basel) | 2024 | 38674389 | PubTator, text mining | PubMed |
| Differential Effects of Genetic Polymorphism on Comorbid Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease. | Clin Gastroenterol Hepatol | 2024 | 38604296 | PubTator, text mining | PubMed |
| Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort. | J Hepatol | 2024 | 38582304 | PubTator, text mining | PubMed |
| Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysis. | Biol Sex Differ | 2024 | 38532495 | PubTator, text mining | PubMed |
| Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma. | Semin Liver Dis | 2024 | 38499207 | PubTator, text mining | PubMed |
| Altered lipid metabolism and the development of metabolic-associated fatty liver disease. | Curr Opin Lipidol | 2024 | 38484227 | PubTator, text mining | PubMed |
| Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism. | Curr Opin Lipidol | 2024 | 38465912 | PubTator, text mining | PubMed |
| Combination of heterozygous APOB gene mutation with PNPLA3 and TM6SF2 variants promotes steatotic liver disease, cirrhosis and HCC development. | Liver Int | 2024 | 38421084 | PubTator, text mining | PubMed |
| PARVB and HSD17B13 variants are associated with nonalcoholic fatty liver disease in children. | J Gastroenterol Hepatol | 2024 | 38418429 | PubTator, text mining | PubMed |
| Inhibition of Cellular Factor TM6SF2 Suppresses Secretion Pathways of Hepatitis B, Hepatitis C, and Hepatitis D Viruses. | J Infect Dis | 2024 | 38408366 | PubTator, text mining | PubMed |
| Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. | Hepatology | 2024 | 38381705 | PubTator, text mining | PubMed |
| Psoriasis and steatotic liver disease: Are PNPLA3 and TM6SF2 polymorphisms suitable for the hepato-dermal axis hypothesis? | Ann Hepatol | 2024 | 38360269 | PubTator, text mining | PubMed |
| Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children's Hospital of Eastern Ontario grossing protocol. | Ther Adv Endocrinol Metab | 2024 | 38322111 | PubTator, text mining | PubMed |
| Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review. | Transl Gastroenterol Hepatol | 2024 | 38317742 | PubTator, text mining | PubMed |
| The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective. | Clin Mol Hepatol | 2024 | 38311818 | PubTator, text mining | PubMed |
| Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies. | Chin Med | 2024 | 38310315 | PubTator, text mining | PubMed |
| Alcohol-associated liver disease. | J Clin Invest | 2024 | 38299591 | PubTator, text mining | PubMed |
| From MASH to HCC: the role of Gas6/TAM receptors. | Front Immunol | 2024 | 38298195 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53345/papers?page=10